Genentech | pharmaphorum

Saturday 7 February 2026

Genentech

News

Breakthrough designation for Roche/Novartis' Xolair in food allergies

Breakthrough designation for Roche/Novartis' Xolair in food ...

Xolair, a drug developed 15 years ago by Roche and Novartis, received a breakthrough designation from the US regulator in a new food allergy indication.

News

FDA approve Rituxan

Genentech’s Rituxan approved for rare skin disease

The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.

Partner Content

Calling all Microbiologists - 5 great reasons to be in San Diego

Partner Content

Calling all Microbiologists - 5 great reasons to be in San D...

Pharmaceutical Microbiology West Coast Conference 2018

Partner Content

HPAPI

Partner Content

Hear from Genentech and Cristalia Produtos Quimicos Farmaceu...

HPAPI 2018

News

digital illustration neurons

Roche and AC Immune's Alzheimer's drug on right track

Data suggest high dose used in phase 3 trial is most effective

News

Roche Rituxan approval

Three's a crowd as Tecentriq approved in lung cancer

Cancer immunotherapy approved in second line.